GPT and hydrops fetalis: As shown in Figs 4 and 5, the 4-week fenofibrate treatment did not change body weight, the quantity of mesenteric fat (Fig. 4A,C), hepatic concentrations of glycerol, muscle and adipose tissue TG concentrations (Fig. 4E–G), or plasma FFA, LDL and MDA concentrations, as well as AST, and ALT activities in either the HF or LF groups (Fig. 5C,D,F–H), but significantly decreased the hepatosomatic index (Fig. 4B).